Whalegun
Home

Regeneron Pharmaceuticals REGN spent $570K on lobbying in Q3 2025 · Trade, Taxation and 3 more issues

Trade details

Type
Lobbying report
Amount
$570,000
Quarter
Q3 2025
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
25/10/20

Down 6.6% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $570K on lobbying in Q3 2025 · Trade, Taxation and 3 more issues | Whalegun